| Record ID | marc_loc_2016/BooksAll.2016.part35.utf8:157441119:1977 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part35.utf8:157441119:1977?format=raw |
LEADER: 01977cam a22003374a 4500
001 2008052079
003 DLC
005 20090812085636.0
008 081201s2009 enkaf b 001 0 eng
010 $a 2008052079
016 7 $a101490370$2DNLM
020 $a9780470092545 (HB)
020 $a0470092548 (HB)
020 $a9780470092552 (PB)
020 $a0470092556 (PB)
035 $a(OCoLC)ocn216941051
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dYDXCP$dBAKER$dBWKUK$dCDX$dDLC
042 $apcc
050 00 $aRC271.C5$bA35 2009
060 00 $a2009 E-866
060 10 $aQZ 267$bA298c 2009
082 00 $a616.99/4061$222
100 1 $aAirley, Rachel.
245 10 $aCancer chemotherapy /$cRachel Airley.
260 $aChichester, UK ;$aHoboken, NJ :$bWiley-Blackwell,$c2009.
300 $ax, 341 p., [8] p. of plates :$bill. (some col.) ;$c25 cm.
504 $aIncludes bibliographical references (p. [299]-330) and index.
505 0 $aCancer epidemiology -- Histopathology of cancer -- Carcinogenesis, malignant transformation, and progression -- Molecular biology of cancer : oncogenes and tumour suppressor genes -- Tumour metastasis : a convergence of many theories -- Health professionals in the treatment of cancer -- Principles of cancer chemotherapy -- Classic anticancer agents -- The philosophy of cancer research -- Novel anticancer agents -- Clinical trials -- Tumour hypoxia -- Antiangiogenic and antivascular agents -- Tyrosine kinase inhibitors -- Ras inhibitors -- Inhibitors of the Akt/PKB pathway -- Targeting stress proteins: HSP90 inhibitors -- The proteasome -- Checkpoint protein kinases as novel targets : mammalian target of rapamycin (mTOR) -- Telomerase -- Histone deacetylase : an epigenetic drug target -- Pharmaceutical problems in cancer chemotherapy -- Oncology pharmacy at home and abroad -- Practice exam questions.
650 0 $aCancer$xChemotherapy.
650 12 $aNeoplasms$xdrug therapy.
650 22 $aAntineoplastic Agents$xtherapeutic use.